A detailed history of Legal & General Group PLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Legal & General Group PLC holds 909,176 shares of AZN stock, worth $60.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
909,176
Previous 909,176 -0.0%
Holding current value
$60.2 Million
Previous $70.8 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$76.67 - $87.62 $1.21 Million - $1.38 Million
-15,796 Reduced 1.71%
909,176 $70.8 Million
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $1.1 Million - $1.33 Million
-16,503 Reduced 1.75%
924,972 $72.1 Million
Q1 2024

Jul 01, 2024

BUY
$61.03 - $69.57 $496,051 - $565,464
8,128 Added 0.87%
941,475 $63.8 Million
Q1 2024

May 14, 2024

SELL
$61.03 - $69.57 $943,523 - $1.08 Million
-15,460 Reduced 1.63%
933,347 $63.2 Million
Q4 2023

Feb 15, 2024

SELL
$61.89 - $69.28 $2.74 Million - $3.07 Million
-44,323 Reduced 4.46%
948,807 $63.9 Million
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $277,104 - $306,374
-4,273 Reduced 0.43%
993,130 $67.3 Million
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $17.4 Million - $18.9 Million
-249,401 Reduced 20.0%
997,403 $71.4 Million
Q1 2023

May 15, 2023

SELL
$63.15 - $71.6 $5.98 Million - $6.78 Million
-94,732 Reduced 7.06%
1,246,804 $86.5 Million
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $6.66 Million - $8.65 Million
-122,869 Reduced 8.39%
1,341,536 $91 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $39.3 Million - $101 Million
-741,455 Reduced 33.61%
1,464,405 $80.3 Million
Q2 2022

Aug 22, 2022

SELL
$59.26 - $71.14 $36.8 Million - $44.1 Million
-620,559 Reduced 21.96%
2,205,860 $146 Million
Q1 2022

May 16, 2022

SELL
$55.72 - $67.12 $68.1 Million - $82 Million
-1,222,429 Reduced 30.19%
2,826,419 $187 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $77.1 Million - $91.1 Million
-1,427,165 Reduced 26.06%
4,048,848 $236 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $304 Million - $333 Million
5,476,013 New
5,476,013 $329 Million
Q4 2020

Feb 12, 2021

SELL
$48.52 - $58.02 $29.6 Million - $35.4 Million
-610,660 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$53.07 - $61.1 $32.4 Million - $37.3 Million
610,660 New
610,660 $33.5 Million
Q4 2019

Feb 13, 2020

SELL
$42.46 - $50.46 $10.2 Million - $12.1 Million
-240,448 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$40.12 - $45.47 $9.65 Million - $10.9 Million
240,448 New
240,448 $10.7 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.